NASDAQ:PETS PetMed Express Q3 2026 Earnings Results & Report $1.06 -0.15 (-11.98%) Closing price 11/11/2026 04:00 PM EasternExtended Trading$1.13 +0.06 (+5.92%) As of 04:39 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. PetMed Express missed analyst expectations on both earnings and revenue in its Q3 2026 results, released February 5, 2026. The company reported EPS of -$0.50 versus the -$0.06 consensus estimate, while revenue of $40.66 million fell short of the $54.04 million estimate by $13.38 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateFebruary 5, 2026TimeAfter Market ClosesConference Call DateFebruary 4, 2026Conference Call6:00 PM ET PetMed Express EPS ResultsActual EPS-$0.50Consensus EPS -$0.06Beat/MissMissed by -$0.44One Year Ago EPSN/AEPS Beat Rate2 of last 8 quartersPetMed Express Revenue ResultsActual Revenue$40.66 millionExpected Revenue$54.04 millionBeat/MissMissed by -$13.38 millionYoY Revenue GrowthN/AConference Call ResourcesQuarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) PetMed Express Q3 2026 Earnings FAQ Did PetMed Express beat earnings estimates for Q3 2026? PetMed Express (NASDAQ:PETS) reported earnings of -$0.50 per share for Q3 2026, missing the consensus estimate of -$0.06. The report was announced on Thursday, February 5, 2026. What was PetMed Express' revenue for Q3 2026? PetMed Express reported revenue of $40.66 million for Q3 2026, against a consensus estimate of $54.04 million. PetMed Express Earnings HeadlinesPetMeds outlines turnaround plan as customer acquisition cost falls 32% to $51November 10 at 8:24 PM | seekingalpha.comPetMed Express Q2 2027 Earnings Call TranscriptNovember 10 at 5:11 PM | benzinga.comI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th. | Behind the Markets (Ad)PetMeds® Announces Second Quarter Financial ResultsNovember 10 at 4:05 PM | globenewswire.comPetMed Express Q2 earnings previewNovember 9 at 6:11 PM | msn.comPetMeds Announces Strategic Partnership with Pet Supermarket to Expand Pharmacy Offering Across Retail and Digital ChannelsNovember 9 at 4:05 PM | globenewswire.comSee More PetMed Express Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like PetMed Express? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PetMed Express and other key companies, straight to your email. Email Address About PetMed ExpressPetMed Express (NASDAQ:PETS), doing business as PetMeds, is an online retailer of prescription and nonprescription medications and health products for dogs, cats and other household pets. The company offers products used to treat or prevent conditions such as allergies, infections, parasites and chronic illnesses, including prescription medicines, flea and tick treatments, heartworm preventatives, supplements and other animal-health products. In addition to medications, PetMeds sells pet food, treats, vitamins, wellness products and selected supplies. Customers can place orders through the company’s website and other direct-to-consumer channels, with prescription orders generally requiring authorization from a licensed veterinarian. PetMeds primarily serves pet owners in the United States. Founded in 1996 and previously known as 1-800-PetMeds, the company has built its business around convenient home delivery and consumer access to pet-health products. PetMed Express is headquartered in Delray Beach, Florida, and its common stock trades on the Nasdaq Capital Market under the symbol PETS.View PetMed Express ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Keeping AI Cool: AAON Rides the AI Heatwave to Record GrowthCan Constellation Energy's Contracts Power a Stock Rebound?IonQ Raised the Bar, But 3 Quantum Rivals Face Tough QuestionsAmazon's Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI DemandAST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn't Going AwayPowering Up the Moon: Redwire’s $40 Million NASA Award Upcoming Earnings Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)PDD (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
